Elevated angiogenin levels in synovial fluid from patients with inflammatory arthritis and secretion of angiogenin by cultured synovial fibroblasts

Clinical and Experimental Immunology

Volumn 132, Issue 1, 2003, Pages 163-168

  Lioté, Frédéric ^a   Champy, R ^a   Moenner, M ^b   Boval Boizard, B ^a   Badet, J ^b  

^a CENTRE VIGGO PETERSEN   (France)

^b INSERM   (France)

Author keywords

Angiogenin; Crystal induced inflammation; Osteoarthritis; Rheumatoid arthritis; Synovial fibroblasts

Indexed keywords

ANGIOGENIN;

ANGIOGENESIS; ARTHRITIS; ARTICLE; BLOOD LEVEL; CELL CULTURE; CHONDROCALCINOSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; GOUT; HUMAN; HUMAN CELL; LEUKOCYTE; MAJOR CLINICAL STUDY; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN SECRETION; RADIOIMMUNOASSAY; REMISSION; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID LEVEL; SYNOVITIS;

ANALYSIS OF VARIANCE; ARTHRITIS; ARTHRITIS, INFECTIOUS; ARTHRITIS, PSORIATIC; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; FIBROBLASTS; HUMANS; LEUKOCYTES, MONONUCLEAR; OSTEOARTHRITIS; RIBONUCLEASE, PANCREATIC; STATISTICS, NONPARAMETRIC; SYNOVIAL FLUID;

EID: 0037386222     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2003.02117.x     Document Type: Article

References (46)

1. Harris ED Jr. Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med 1990; 322:1277-89.
2. Goldenberg DL, Cohen AS. Synovial membrane histopathology in the differential diagnosis of rheumatoid arthritis, gout, pseudogout, systemic lupus erythematosus, infectious arthritis and degenerative joint disease. Medicine (Baltimore) 1978; 57:239-52.
3. Brown RA, Weiss JB. Neovascularisation and its role in the osteoarthritic process. Ann Rheum Dis 1988; 47:881-5.
4. Walsh DA. Angiogenesis and arthritis. Rheumatology 1999; 38:103-12.
5. Koch AE. The role of angiogenesis in rheumatoid arthritis: recent developments. Ann Rheum Dis 2000; 59:i65-i71.
6. Folkman J, Klagsbrun M. Angiogenic factors. Science 1987; 235:442-77.
7. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med 1995; 1:27-31.
8. Fontana A, Hengartner H, Weber E, Fehr K, Grob PJ, Cohen G. Interleukin 1 activity in the synovial fluid of patients with rheumatoid arthritis. Rheumatol Int 1982; 2:49-53.
9. Al-Balaghi S, Strom H, Moller E. B cell differentiation factor in synovial fluid of patients with rheumatoid arthritis. Immunol Rev 1984; 78:7-23.
10. Seitz M, Dewald B, Ceska M, Gerber N, Baggiolini M. Interleukin-8 in inflammatory rheumatic diseases. Synovial fluid levels, relation to rheumatoid factors, production by mononuclear cells, and effects of gold sodium thiomalate and methotrexate. Rheumatol Int 1992; 12:159-64.
11. Husby G, Williams RC Jr. Synovial localization of tumor necrosis factor in patients with rheumatoid arthritis. J Autoimmun 1988; 1:363-71.
12. Sano H, Forough R, Maier JA, Case JP, Jackson A, Engleka K, Maciag T, Wilder RL. Detection of high levels of heparin binding growth factor-1 (acidic fibroblast growth factor) in inflammatory arthritic joints. J Cell Biol 1990; 110:1417-26.
13. Remmers EF, Sano H, Wilder RL. Platelet-derived growth factors and heparin-binding (fibroblast) growth factors in the synovial tissue pathology of rheumatoid arthritis. Semin Arthritis Rheum 1991; 21:191-9.
14. Koch AE, Halloran MM, Hosaka S et al. Hepatocyte growth factor. A cytokine mediating endothelial migration in inflammatory arthritis. Arthritis Rheum 1996; 39:1566-75.
15. Nagashima M, Hasegawa J, Kato K, Yamazaki J, Nishigai K, Ishiwata T, Asano G, Yoshino S. Hepatocyte growth factor (HGF), HGF activator, and c-Met in synovial tissues in rheumatoid arthritis and osteoarthritis. J Rheumatol 2001; 28:1772-8.
16. Thornton SC, Por SB, Penny R, Richter M, Shelley L, Breit SN. Identification of the major fibroblast growth factors released spontaneously in inflammatory arthritis as platelet derived growth factor and tumour necrosis factor-alpha. Clin Exp Immunol 1991; 86:79-86.
17. Fava R, Olsen N, Keski-Oja J, Moses H, Pincus T. Active and latent forms of transforming growth factor beta activity in synovial effusions. J Exp Med 1989; 169:291-6.
18. Koch AE, Harlow LA, Haines GK, Amento EP, Unemori EN, Wong WL, Pope RM, Ferrara N. Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. J Immunol 1994; 152:4149-56.
19. Nagashima M, Yoshino S, Ishiwata T, Asano G. Role of vascular endothelial growth factor in angiogenesis of rheumatoid arthritis. J Rheumatol 1995; 22:1624-30.
20. Hosaka S, Shah MR, Barquin N, Haines GK, Koch AE. Expression of basic fibroblast growth factor and angiogenin in arthritis. Pathobiology 1995; 63:249-56.
21. Ikeda M, Hosoda Y, Hirose S, Okada Y, Ikeda E. Expression of vascular endothelial growth factor isoforms and their receptors Flt-1, KDR, and neuropilin-1 in synovial tissues of rheumatoid arthritis. J Pathol 2000; 191:426-33.
22. Uchida T, Nakashima M, Hirota Y, Miyazaki Y, Tsukazaki T, Shindo H. Immunohistochemical localisation of protein tyrosine kinase receptors Tie-1 and Tie-2 in synovial tissue of rheumatoid arthritis: correlation with angiogenesis and synovial proliferation. Ann Rheum Dis 2000; 59:607-14.
23. Badet J. Angiogenin, a potent mediator of angiogenesis: Biological, biochemical and structural properties. Pathologie Biologie 1999; 47:345-51.
24. Fett JW, Strydom DJ, Lobb RR, Alderman EM, Bethune JL, Riordan JF, Vallee BL. Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry 1985; 24:5480-6.
25. King TV, Vallee BL. Neovascularisation of the meniscus with angiogenin. An experimental study in rabbits. J Bone Joint Surg (Br) 1991; 73-B: 587-90.
26. Soncin F, Strydom DJ, Shapiro R. Interaction of heparin with human angiogenin. J Biol Chem 1997; 272:9818-24.
27. Shapiro R, Riordan JF, Vallee BL. Characteristic ribonucleolytic activity of human angiogenin. Biochemistry 1986; 25:3527-32.
28. Olson KA, Fett JW, French TC, Key ME, Vallee BL. Angiogenin antagonists prevent tumor growth in vivo. Proc Natl Acad Sci USA 1995; 92:442-6.
29. Olson KA, Byers HR, Key ME, Fett JW. Prevention of human prostate tumor metastasis in athymic mice by antisense targeting of human angiogenin. Clin Cancer Res 2001; 7:3598-605.
30. Olson KA, Byers HR, Key ME, Fett JW. Inhibition of prostate carcinoma establishment and metastatic growth in mice by an antiangiogenin monoclonal antibody. Int J Cancer 2002; 98:923-9.
31. Olson KA, Verselis SJ, Fett JW. Angiogenin is regulated in vivo as an acute phase protein. Biochem Biophys Res Commun 1998; 242:480-3.
32. Verselis SJ, Olson KA, Fett JW. Regulation of angiogenin expression in human HepG2 hepatoma cells by mediators of the acute-phase response. Biochem Biophys Res Commun 1999; 259:178-84.
33. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31:315-24.
34. Lioté F, Boval-Boizard B, Weill D, Kuntz D, Wautier JL. Blood monocyte activation in rheumatoid arthritis, increased monocyte adhesiveness, integrin expression, and cytokine release. Clin Exp Immunol 1996; 106:13-19.
35. Moenner M, Gusse M, Hatzi E, Badet J. The widespread expression of angiogenin in different human cells suggests a biological function not only related to angiogenesis. Eur J Biochem 1994; 226:483-90.
36. Hatzi E, Badet J. Expression of receptors for human angiogenin in vascular smooth muscle cells. Eur J Biochem 1999; 260:825-32.
37. Bläser J, Triebel S, Kopp C, Tschesche H. A highly sensitive immunoenzymometric assay for the determination of angiogenin. Eur J Clin Chem Clin Biochem 1993; 31:513-16.
38. Polverini PJ. How the extracellular matrix and macrophages contribute to angiogenesis-dependent diseases. Eur J Cancer 1996; 32A:2430-7.
39. Sunderkötter C, Steinbrink K, Goebeler M, Bhardwaj R, Sorg C. Macrophages and angiogenesis. J Leukocyte Biol 1994; 55:410-22.
40. Etoh T, Shibuta K, Barnard GF, Kitano S, Mori M. Angiogenin expression in human colorectal cancer. The role of focal macrophage infiltration. Clin Cancer Res 2000; 6:3545-51.
41. Rybak SM, Fett JW, Yao Q-Z, Vallee BL. Angiogenin mRNA in human tumor and normal cells. Biochem Biophys Res Commun 1987; 146:1240-8.
42. Egesten A, Dyer KD, Batten D, Domachowske JB, Rosenberg HF. Ribonucleases and host defense: identification, localization and gene expression in adherent monocytes in vitro. Biochem Biophys Acta 1997; 1358:255-60.
43. Tschesche H, Kopp C, Hörl WH, Hempelmann U. Inhibition of degranulation of polymorphonuclear leukocytes by angiogenin and its tryptic fragment. J Biol Chem 1994; 269:30274-80.
44. Matousek J, Soucek J, Riha J, Zankel TR, Benner SA. Immunosuppressive activity of angiogenin in comparison with bovine seminal ribonuclease and pancreatic ribonuclease. Comp Biochem Physiol 1995; 112B:235-41.
45. Hartmann A, Kunz M, Köstlin S, Gillitzer R, Toksoy A, Bröcker E-B, Klein CE. Hypoxia-induced up-regulation of angiogenin in human malignant melanoma. Cancer Res 1999; 59:1578-83.
46. Koga K, Osuga Y, Tsutsumi O et al. Evidence for the presence of angiogenin in human follicular fluid and the up-regulation of its production by human chorionic gonadotropin and hypoxia. J Clin Endocrinol Metab 2000; 85:3352-5.